• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-内酰胺酶研究的最新进展及其对未来的影响。

Recent developments in beta-lactamase research and their implications for the future.

作者信息

Bush K

机构信息

Squibb Institute for Medical Research, Princeton, New Jersey 08543-4000.

出版信息

Rev Infect Dis. 1988 Jul-Aug;10(4):681-90. doi: 10.1093/clinids/10.4.681.

DOI:10.1093/clinids/10.4.681
PMID:3055169
Abstract

beta-Lactamases, major determinants of bacterial resistance to beta-lactam antibiotics, can be classified into specific molecular classes following identification of active-site amino acid or nucleotide sequences. The use of gene probes for epidemiologic purposes is becoming commoner. A semiempirical classification scheme has been proposed using substrate profiles and inhibition by clavulanic acid and aztreonam as criteria. Class 1 cephalosporinases are potently inhibited by aztreonam but poorly inhibited by clavulanate, whereas class 2 penicillinases and broad-spectrum beta-lactamases have very poor affinities for aztreonam but are inhibited by clavulanic acid. Class 3 beta-lactamases include the metalloenzymes. Resistance to beta-lactam antibiotics can be related to many beta-lactamase-mediated phenomena, including increased frequency of beta-lactamase production in clinical isolates, wider distribution of beta-lactamase-mediating plasmids, production of multiple beta-lactamases, induction of chromosomal class 1 cephalosporinases, selection of depressed mutants for production of class 1 enzymes, leakage of beta-lactamase from gram-negative organisms, functions of penicillin-binding proteins as beta-lactamases, and identification of novel beta-lactamases.

摘要

β-内酰胺酶是细菌对β-内酰胺类抗生素耐药的主要决定因素,在确定活性位点氨基酸或核苷酸序列后,可分为特定的分子类别。用于流行病学目的的基因探针的使用正变得越来越普遍。已提出一种半经验分类方案,以底物谱以及克拉维酸和氨曲南的抑制作用作为标准。1类头孢菌素酶被氨曲南强烈抑制,但被克拉维酸盐抑制较弱,而2类青霉素酶和广谱β-内酰胺酶对氨曲南的亲和力非常低,但被克拉维酸抑制。3类β-内酰胺酶包括金属酶。对β-内酰胺类抗生素的耐药性可能与许多β-内酰胺酶介导的现象有关,包括临床分离株中β-内酰胺酶产生频率增加、β-内酰胺酶介导的质粒分布更广泛、多种β-内酰胺酶的产生、染色体1类头孢菌素酶的诱导、产生1类酶的低表达突变体的选择、β-内酰胺酶从革兰氏阴性菌的泄漏、青霉素结合蛋白作为β-内酰胺酶的功能以及新型β-内酰胺酶的鉴定。

相似文献

1
Recent developments in beta-lactamase research and their implications for the future.β-内酰胺酶研究的最新进展及其对未来的影响。
Rev Infect Dis. 1988 Jul-Aug;10(4):681-90. doi: 10.1093/clinids/10.4.681.
2
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.β-内酰胺酶对细菌耐药性的作用以及抑制β-内酰胺酶的机制。
Am J Med. 1985 Nov 29;79(5B):2-12. doi: 10.1016/0002-9343(85)90123-8.
3
[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].[肠杆菌科细菌对β-内酰胺酶抗生素的耐药机制]
Acta Med Croatica. 2004;58(4):307-12.
4
Epidemiology of β-Lactamase-Producing Pathogens.产β-内酰胺酶病原体的流行病学。
Clin Microbiol Rev. 2020 Feb 26;33(2). doi: 10.1128/CMR.00047-19. Print 2020 Mar 18.
5
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.对第三代头孢菌素耐药的革兰氏阴性杆菌:β-内酰胺酶特性及对Sch 34343的敏感性
J Antimicrob Chemother. 1985 Jun;15 Suppl C:119-32. doi: 10.1093/jac/15.suppl_c.119.
6
Meeting the challenges of beta-lactamases.应对β-内酰胺酶的挑战。
J Antimicrob Chemother. 1993 Jan;31 Suppl A:1-8. doi: 10.1093/jac/31.suppl_a.1.
7
β-Lactamases: A Focus on Current Challenges.β-内酰胺酶:聚焦当前挑战。
Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):a025239. doi: 10.1101/cshperspect.a025239.
8
Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.β-内酰胺类与β-内酰胺酶抑制剂联合制剂:抗菌活性及酶抑制效果
Am J Health Syst Pharm. 1995 Mar 15;52(6 Suppl 2):S15-22. doi: 10.1093/ajhp/52.6_Suppl_2.S15.
9
The evolution of beta-lactamases.β-内酰胺酶的进化
Ciba Found Symp. 1997;207:152-63; discussion 163-6.
10
[Mechanisms of bacterial resistance to beta-lactams by beta-lactamases].[β-内酰胺酶介导细菌对β-内酰胺类抗生素耐药的机制]
Nihon Rinsho. 1997 May;55(5):1225-30.

引用本文的文献

1
Isolation, Enrichment and Analysis of Aerobic, Anaerobic, Pathogen-Free and Non-Resistant Cellulose-Degrading Microbial Populations from Methanogenic Bioreactor.从产甲烷生物反应器中分离、富集及分析需氧、厌氧、无病原体和无抗性的纤维素降解微生物群体
Genes (Basel). 2025 Apr 30;16(5):551. doi: 10.3390/genes16050551.
2
Review of phenotypic assays for detection of extended-spectrum β-lactamases and carbapenemases: a microbiology laboratory bench guide.表型检测法用于检测超广谱β-内酰胺酶和碳青霉烯酶的评价:微生物学实验室手册。
Afr Health Sci. 2020 Sep;20(3):1090-1108. doi: 10.4314/ahs.v20i3.11.
3
Past and Present Perspectives on β-Lactamases.
β-内酰胺酶的过去与现在观点。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.01076-18. Print 2018 Oct.
4
Carbapenemases: the versatile beta-lactamases.碳青霉烯酶:多功能β-内酰胺酶
Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents. doi: 10.1128/CMR.00001-07.
5
A functional classification scheme for beta-lactamases and its correlation with molecular structure.β-内酰胺酶的功能分类方案及其与分子结构的相关性。
Antimicrob Agents Chemother. 1995 Jun;39(6):1211-33. doi: 10.1128/AAC.39.6.1211.
6
Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.气单胞菌属中由可诱导的β-内酰胺酶引起的对β-内酰胺类抗生素的耐药性,这些β-内酰胺酶对青霉素、头孢菌素和碳青霉烯类抗生素具有活性。
Antimicrob Agents Chemother. 1988 Sep;32(9):1314-9. doi: 10.1128/AAC.32.9.1314.
7
Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.β-内酰胺酶的分类:1组、2a组、2b组和2b'组。
Antimicrob Agents Chemother. 1989 Mar;33(3):264-70. doi: 10.1128/AAC.33.3.264.
8
Characterization of beta-lactamases.β-内酰胺酶的特性分析
Antimicrob Agents Chemother. 1989 Mar;33(3):259-63. doi: 10.1128/AAC.33.3.259.
9
Novel plasmid-mediated resistance to ceftazidime of a clinical isolate of Klebsiella pneumoniae.肺炎克雷伯菌临床分离株对头孢他啶的新型质粒介导耐药性
CMAJ. 1990 Mar 15;142(6):597-8.
10
Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics.类鼻疽杆菌,泰国一种常见的病原体,对许多抗生素的杀菌作用具有抗性。
Antimicrob Agents Chemother. 1991 Mar;35(3):484-9. doi: 10.1128/AAC.35.3.484.